HCA Healthcare stock gains 3.84 percent as BMO starts coverage

Published on 09/23/2026 at 14:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HCA Healthcare stock traded at USD 442.33 on September 22, 2026, up 3.84 percent, while BMO set a USD 495 target. Quarterly revenue reached USD 20.23 billion.

Fotorealistisches Krankenhaus-Außengebäude mit Ambulanzen am Haupteingang bei Sonnenuntergang — HCA Healthcare US40412C1018 zeigt einen modernen Krankenhaus Campus mit Notaufnahme bei goldenem Abendlicht, Illustration mit AI erstellt.

HCA Healthcare stock (ISIN US40412C1018) traded at USD 442.33 on the NYSE on September 22, 2026, up 3.84 percent from the prior close. The move followed fresh analyst coverage, with BMO Capital initiating an Outperform rating and a USD 495 price target on September 22, 2026.

BMO sets a USD 495 target

According to TipRanks on September 22, 2026, BMO Capital began coverage with an Outperform rating and a USD 495 price target. That target stands USD 52.67 above the September 22 closing price, implying a 11.9 percent difference based on the quoted levels.

A separate Investing.com report dated September 22, 2026, said Bernstein raised its price target to USD 426 while maintaining Market Perform, whereas Truist Securities lowered its target to USD 495 while retaining Buy. KeyBanc also reduced its target to USD 435 and kept an Overweight rating.

Revenue reached USD 20.23 billion

HCA Healthcare's latest reported quarter produced USD 20.23 billion in revenue and USD 7.59 in earnings per share, according to MarketBeat on September 22, 2026, which identified the figures as the quarter reported on July 24, 2026. EPS exceeded the consensus estimate of USD 7.56 by USD 0.03, while revenue surpassed the USD 19.76 billion estimate by USD 0.47 billion. Revenue was 8.7 percent higher than in the comparable quarter of 2025, when EPS was USD 6.84.

The same report said HCA declared a quarterly dividend of USD 0.78 per share, equivalent to USD 3.12 annualized, with payment scheduled for September 30, 2026. The September 16, 2026 ex-dividend date is historical relative to the quoted September 22 market data.

Stock remains below yearly high

MarketBeat data showed a 52-week range of USD 353.99 to USD 556.52, with volume of 727,390 shares and market capitalization of USD 95.77 billion as of September 22, 2026. The closing price was USD 114.19 below the 52-week high and USD 88.34 above the low.

For investors, the contrast is clear: the latest quarter combined an 8.7 percent year-over-year revenue increase with a modest USD 0.03 EPS beat, while analyst targets ranged from USD 426 to USD 495 in the September 22 coverage updates.

HCA stock closes at USD 442.33

HCA Healthcare stock closed at USD 442.33 on the NYSE on September 22, 2026, after gaining 3.84 percent. The same market snapshot placed capitalization at USD 95.77 billion and the 52-week range at USD 353.99 to USD 556.52.